日韩中文字幕永久免费观看电剧_亚洲国产中文av网站1区_这里只有精品无卡顿_黄色影院在线观看视频_先锋音影亚洲自拍_熟妇高潮一区二区精品色欲_欧美巨大粗爽av在线观看_九九中文字幕天堂女人_亚洲国产日韩欧美综合久久_真实国产老熟女粗口
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.04.18
關(guān)于開(kāi)展2014年遠(yuǎn)期外匯交易情況的公告
2014.04.18
關(guān)于注銷(xiāo)全資子公司的公告
2014.04.18
關(guān)于舉行2013年度報(bào)告網(wǎng)上說(shuō)明會(huì)的公告
2014.04.18
關(guān)于公司募集資金年度存放與實(shí)際使用情況的鑒證報(bào)告
2014.04.18
獨(dú)立董事候選人聲明（徐濱）
2014.04.18
獨(dú)立董事候選人聲明（解凍）
2014.04.15
2014年第一季度業(yè)績(jī)預(yù)告
2014.04.11
北京市中倫律師事務(wù)所關(guān)于公司重大資產(chǎn)購(gòu)買(mǎi)之實(shí)施情況的法律意見(jiàn)書(shū)
2014.04.11
董事會(huì)關(guān)于重大資產(chǎn)重組的實(shí)施情況報(bào)告書(shū)
2014.04.11
華英證券有限責(zé)任公司關(guān)于公司重大資產(chǎn)購(gòu)買(mǎi)實(shí)施情況之獨(dú)立財(cái)務(wù)顧問(wèn)核查意見(jiàn)
第一頁(yè)
上一頁(yè)
114
115
116
117
118
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
